Equity Research, Broker Reports, and media content on ESPERITE

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about ESPERITE
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on ESPERITE. We currently have 0 research reports from 0 professional analysts.

Open
1.30
Volume
0.1m
Range
1.30/1.30
Market Cap
13,571,083m
52 Week
1.20/2.80
Date Source Announcement
31Dec16 06:17 GNW Esperite N.V.: Update on Financing
08Nov16 06:17 GNW Esperite N.V. : Stem Cells, Genetic Tests and Pharmaceuticals
20Oct16 06:17 GNW Esperite N.V. (ESP) expands extracellular vesicles (exosomes) products portfolio to include inflammatory bowel disease. The Cell Factory develops therapy for Crohn's disease.
30Sep16 06:17 GNW Esperite (ESP) leads international consortium for clinical translation of extracellular vesicles use in various therapies
29Aug16 06:17 GNW Esperite N.V. (ESP) announces additional information on envisaged financing
23Aug16 06:17 GNW Esperite N.V. (ESP) publishes revenue increase of 6% compared to HY1 2015 and 8% to HY2 2015; Significant EBITDA improvement from minus EUR 2.8 million in HY2 2015 to minus EUR 1.5 million HY 2016
15Jun16 06:17 GNW Esperite N.V.: important recurrent financial improvements from Laboratory transfer and cost reduction program Galaxy
  • Frequency of research reports

     

  • Research reports on

    ESPERITE

  • Providers covering

    ESPERITE